Question

I am trying to figure out the best approach on this psy pharm scenario:

When a patient is admitted, we generally may not know of their PTSD until we are able to detox and then it provides for a "clearer" dialogue. I have been trying to determine if when a patient is admitted, and they are in a severe anxiety crisis, and they are under the influence, I have been finding research that suggests that benzodiazepines (possible Xanax) are suitable for immediate decrease of anxiety; however, because of their addictive potential, they should only be used for a short period of time. Contrary research indicates that benzos should not be used and a better pharmacological intervention is Clonidine and continue this, along with SSRI's and possibly consider for further treatment of PTSD. Do you have any insight on the best way to approach this?

Thanks for your help

Answer 1

Selective serotonin reuptake inhibitors (SSRI) will reduce the severe anxiety symptoms effectively. SSRIs such as sertraline and paroxetine are considered as the first-line pharmacological management for PTSD. These medications are considered as good due to their efficacy, tolerability and safety.   Certain studies also reported effectiveness of Buspirone, imipramine, and monoamine oxidase inhibitors. In addition, psychotherapeutic interventions such as cognitive behaviour therapy, EMDR, and hypnosis would be effective along with the pharmacological management.